Who owns HEPION PHARMACEUTICALS INC COM NEW?
- Ticker: HEPA
- CUSIP Number: 426897302
Tip: Access positions for across all investors
Analyze quarterly positions in Hepion Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Hepion Pharmaceuticals stock
Who bought or sold HEPION PHARMACEUTICALS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 390k | $971k | -2% | Mar 2024 |
|
| Vanguard Group | 157k | $392k | -2% | Mar 2024 |
|
| BlackRock | 83k | $207k | 0% | Mar 2024 |
|
| Geode Capital Management | 39k | $97k | 11% | Mar 2024 |
|
| Susquehanna International | 15k | $36k | 0% | Mar 2024 |
|
| Pnc Financial Services | 7.9k | $20k | 174% | Mar 2024 |
|
| Tower Research Capital | 1.9k | $4.7k | -14% | Mar 2024 |
|
| Morgan Stanley | 1.4k | $3.4k | -90% | Mar 2024 |
|
| Group One Trading | 339.00 | $844.008300 | 0% | Mar 2024 |
|
| UBS Group | 183.00 | $366.000000 | 9050% | Mar 2024 |
|
| AdvisorNet Financial | 176.00 | $437.993600 | 100% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 175.00 | $435.995000 | 100% | Mar 2024 |
|
| Advisor Group Holdings | 113.00 | $280.997100 | -1% | Mar 2024 |
|
| Wells Fargo & Company | 34.00 | $85.000000 | 3% | Mar 2024 |
|
| Royal Bank of Canada | 20.00 | $0 | 0% | Mar 2024 |
|
| Barclays | 16.00 | $0 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 11.00 | $26.999500 | -99% | Mar 2024 |
|
| Harbor Investment Advisory | 1.00 | $2.000000 | 0% | Mar 2024 |
|
| Global Retirement Partners | 1.00 | $2.000000 | 0% | Mar 2024 |
|
| Hanson McClain Advisors | 1.00 | $3.000000 | 0% | Mar 2024 |
|
| Benjamin F. Edwards & Company | 1.00 | $0 | 0% | Mar 2024 |
|
| Signature | 1.00 | $2.000000 | 0% | Mar 2024 |
|
| Bank of America Corporation | 1.00 | $2.000000 | -99% | Mar 2024 |
|
Who sold out of Hepion Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Dec 2023 | 13k | $41k |